Alterations in neurotransmitter levels and transcription factor expression following intranasal buprenorphine administration

Alterations in neurotransmitter levels and transcription factor expression following intranasal buprenorphine administration

Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these effects by altering functional neurotransmitter pathways and the expression of important transcription factors; cyclic AMP response element-bin...

Full description

Bibliographic Details
Main Authors:	Sanelisiwe P. Xhakaza, Leon J. Khoza, Advaitaa M. Haripershad, Terisha Ghazi, Shanel Dhani, Cosmas Mutsimhu, Molopa J. Molopa, Nithia P. Madurai, Lorna Madurai, Sanil D. Singh, Nirmala D. Gopal, Hendrik G. Kruger, Thavendran Govender, Anil Chuturgoon, Tricia Naicker, Sooraj Baijnath
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Buprenorphine Opioid addiction Brain-derived neurotrophic factor (BDNF) Cyclic AMP response element-binding protein (CREB) Neurotransmitters
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332221003000

Similar Items

Benefit-Risk Analysis of Buprenorphine for Pain Management
by: Hale M, et al.
Published: (2021-05-01)

Influence of buprenorphine replacement therapy
by: Despotović Milena, et al.
Published: (2017-01-01)

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
by: Jamie Carter, et al.
Published: (2019-05-01)

Transdermal buprenorphine for pain management in children
by: Giorgio Attinà, et al.
Published: (2021-09-01)

Development and Implementation of Tennessee Nonresidential Buprenorphine Treatment Guidelines
by: Erica Schlesinger, et al.
Published: (2018-10-01)

Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection
by: Henriikka Hakomäki, et al.
Published: (2021-04-01)

Comparative evaluation of anaesthetic efficacy and haemodynamic effects of a combination of isobaric bupivacaine with buprenorphine vs. isobaric levobupivacaine with buprenorphine for spinal anaesthesia – A double blinded randomised clinical trial
by: Pushpavathi Ture, et al.
Published: (2019-01-01)

Epidural Naloxone to Prevent Buprenorphine Induced PONV
by: Ashok Jadon, et al.
Published: (2008-01-01)

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients
by: Shane Kaski, et al.
Published: (2021-03-01)

Role of buprenorphine in acute postoperative pain
by: J. Alcázar-Castro, et al.
Published: (2016-07-01)

Recidivism with opiate addicted patients on buprenorphine substitution treatment: Case report
by: Crnić Katarina B., et al.
Published: (2017-01-01)

Histopathological Effects of Cumulative Concentrations of Buprenorphine in Hippocampus of Rats
by: Mohammad Hossein Dehghan, et al.
Published: (2018-06-01)

Buprenorphine: Far Beyond the “Ceiling”
by: Rosmara Infantino, et al.
Published: (2021-05-01)

Buprenorphine as an Efficacious Treatment for Opioid Dependency? A Survey of Counselors Attitudes
by: Agnew, Carol J.
Published: (2011)

Comparison of Sleep Problems in Opioid-Dependent Patients under Methadone and Buprenorphine Treatment
by: Mehdi Madanifard, et al.
Published: (2018-02-01)

Follow-Up: Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City
by: Holt, Hannah, et al.
Published: (2020)

Physicians’ satisfaction with providing buprenorphine treatment
by: Hannah K. Knudsen, et al.
Published: (2019-08-01)

Methadone or buprenorphine? The choice of substitution therapy in pregnant opioid dependent women
by: Jadwiga Zalewska-Kaszubska
Published: (2019-01-01)

Pharmacokinetics of a high-concentration formulation of buprenorphine (Simbadol®) in male dogs
by: Hansford, Jeremy Dustin
Published: (2021)

Routes of non-traditional entry into buprenorphine treatment programs
by: Tiffany Champagne-Langabeer, et al.
Published: (2020-01-01)

Surgical Stress in Rats : The Impact of Buprenorphine on Postoperative Recovery
by: Sundbom, Renée
Published: (2013)

Analgesic Effect of Tramadol and Buprenorphin in Continuous Propofol Anaesthesia
by: Capík I., et al.
Published: (2016-03-01)

Anxiety treatment of opioid dependent patients with buprenorphine: A randomized, double-blind, clinical trial
by: Jamshid Ahmadi, et al.
Published: (2017-01-01)

SUBLINGUAL BUPRENORPHINE VS MIDAZOLAM FOR PREMEDICATION IN CHILDREN
by: V.A HASANI, et al.
Published: (2000-03-01)

Buprenorphine and pain treatment in pediatric patients: an update
by: Vicencio-Rosas E, et al.
Published: (2018-03-01)

A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving
by: Jamshid Ahmadi, et al.
Published: (2019-07-01)

A review of opioid replacement therapy with methadone or buprenorphine on neural development in the newborn
by: Javaid, Maham
Published: (2016)

Single high-dose buprenorphine for opioid craving during withdrawal
by: Jamshid Ahmadi, et al.
Published: (2018-12-01)

Urine analysis of buprenorphine/norbuprenorphine/ naloxone in drugs and driving cases
by: Albert A. Elian, et al.
Published: (2015-07-01)

Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries
by: Arvinder Pal Singh, et al.
Published: (2016-01-01)

Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial
by: Jamshid Ahmadi, et al.
Published: (2017-06-01)

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
by: Phillips-Jackson H, et al.
Published: (2020-05-01)

Buprenorphine unobserved “home” induction: a survey of Ontario’s addiction physicians
by: Anita Srivastava, et al.
Published: (2019-05-01)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
by: Florence Noble, et al.
Published: (2019-01-01)

Post operative analgesia after caesarean section: an experience with intrathecal buprenorphine
by: Sunil Dixit
Published: (2007-01-01)

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
by: Webster LR, et al.
Published: (2016-06-01)

Lipid bound extended release buprenorphine (high and low doses) and sustained release buprenorphine effectively attenuate post‐operative hypersensitivity in an incisional pain model in mice (Mus musculus)
by: Kaela Navarro, et al.
Published: (2021-06-01)

A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
by: David Wiercigroch, et al.
Published: (2021-04-01)

Role of buprenorphine in prolonging the duration of post-operative analgesia in percutaneous nephrolithotomy: Comparison between bupivacaine versus bupivacaine and buprenorphine combination
by: Jonnavithula Nirmala, et al.
Published: (2015-01-01)

Physical birth outcomes in neonates prenatally exposed to buprenorphine - our first experiences
by: Simonovska Natasha, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_8pe3ehcpq244q5vjtr0t1po5er